Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Psyence Biomedical's Enterprise Value is $11.54 Mil.
Psyence Biomedical does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Psyence Biomedical's EV-to-EBIT at this moment.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Psyence Biomedical's Enterprise Value is $11.54 Mil.
Psyence Biomedical does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Psyence Biomedical's EV-to-EBITDA at this moment.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Psyence Biomedical's Enterprise Value is $11.54 Mil.
Psyence Biomedical does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Mar. 2023. Therefore, GuruFocus does not calculate Psyence Biomedical's EV-to-Revenue at this moment.
Psyence Biomedical Enterprise Value Historical Data
The historical data trend for Psyence Biomedical's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Psyence Biomedical Enterprise Value Chart
Psyence Biomedical Annual Data
Trend
Mar21
Mar22
Mar23
Enterprise Value
-
-
-
Psyence Biomedical Semi-Annual Data
Mar21
Mar22
Mar23
Enterprise Value
-
-
-
Competitive Comparison of Psyence Biomedical's Enterprise Value
For the Biotechnology subindustry, Psyence Biomedical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Psyence Biomedical's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Psyence Biomedical's Enterprise Value falls into.
Psyence Biomedical Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Psyence Biomedical's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Psyence Biomedical (NAS:PBM) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
Psyence Biomedical Enterprise Value Related Terms
Thank you for viewing the detailed overview of Psyence Biomedical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Psyence Biomedical (Psyence Biomedical) Business Description
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBM has been successfully added to your